|
⚲
|
| Keyboard |
| Petrichor Healthcare Capital Management LP
✚
|
|
|---|---|
| CRD # | 288664 |
| SEC # | 801-112209 |
| CIK # | 0001913004 |
| AUM | 966.5 M (2026-03-31) |
| Employees | 16 (75% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 646-443-6606 |
| Address | 220 East 42nd Street New York, NY 10017 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 5: Fees and Compensation The Firm’s fees and compensation are fully described in the Funds’ Offering Documents. Pursuant to the Offering Documents, Petrichor receives a management fee during the investment period payable at the maximum rate of 2% per annum on Fund commitments, pro- rated for partial quarters. Following the investment period, Petrichor will receive a management fee payable at a reduced fee on the lesser of Fund commitments or the fair market value of Fund investments, pro-rated for partial quarters. Petrichor deducts management fees directly from the Fund’s assets, quarterly in advance. In general, the proration of management fees is calculated based on the number of days remaining in the applicable quarter, and it would be Petrichor’s policy to refund management fees on a prorated basis upon the termination of Petrichor’s investment management agreement with the Funds. Petrichor renders its services to the Funds at its own expense, including its overhead expenses such as salaries and fringe benefits of its personnel, rent, office equipment, newspapers and other mass-market periodicals, computer equipment, data processing, utilities of any office space maintained, office supplies, secretarial services, and any other overhead-type expenses. All other expenses are borne by the Funds, including operating expenses such as private placement fees, appraisal fees, brokerage fees, expenses relating to hedging, legal and accounting fees, taxes and other governmental charges levied against the Fund, regulatory expenses, “broken deal” expenses, interest expenses incurred in respect of indebtedness, reimbursement of the Funds’ pro-rata share of any reasonable expenses of the Advisory Committee, and other fees or expenses determined by the Advisory Committee to be related to the Fund’s affairs. The inclusion of an expense category in a Fund’s Offering Documents will not impose on Petrichor an obligation to charge an expense (or the full amount of that expense) to that Fund; instead, permitted expenses will be allocated and charged in Petrichor’s discretion to the Fund(s) it deems appropriate. Transaction fees, advisory fees, directors’ fees, investment banking fees, break-up fees, and other similar fees received by Petrichor relating to Fund investments will first be applied to unreimbursed expenses of Petrichor related to the applicable transaction, with 80% of the excess of any such fees applied to offset and reduce future management fees. Organizational expenses up to $1.25 million would have been paid by the Funds, with any excess serving to reduce management fees. Additional information regarding fees and other expenses can be found in each Fund’s Offering Documents. Scion receives operating expense amounts as more fully described in the Scion Life Sciences I, LLC governing documents. The operating expenses charged to Scion Life Sciences I, LLC are reduced by the amount of any transaction fees, break-up fees, advisory fees, director’s fees, monitoring fees, and other similar fees received by Scion or its affiliates. The Funds have entered into letter agreements or other similar agreements (collectively, “Side Letters”) with one or more investors that alter, modify or change the terms of the interests held by such investors. Side Letters provide such investor(s) with additional and/or different rights (including, without limitation, with respect to the carried interest, management fee, withdrawal rights, informational rights or other rights) than the other investors. |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 7: Types of Clients The Firm provides discretionary investment advice solely to its Fund clients, and references throughout this Brochure to “clients” and to the Firm’s related duties and practices on behalf of its clients and/or investors should be construed accordingly. The Investors participating in the Funds are generally “qualified purchasers” (as defined under the 1940 Act). The minimum initial investment in the Funds is generally $5 million, subject to the applicable Fund general partner’s or manager’s, as applicable (the “General Partner”), discretion to accept lesser amounts. |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | POF I Co-Invest LP | [2022-03-31] | 37.0 M | 98.4 M |
| Filed 2021-04-23 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1 · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Scion Life Sciences I LLC | [2022-03-31] | 172.2 M | 296.2 M |
| Filed 2023-03-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Petrichor Opportunities Fund I Intermediate LP | 2021-03-30 | 177.3 M | |
| PE | Petrichor Opportunities Fund I LP | [2017-07-14] | 153.3 M | 394.5 M |
| Filed 2020-07-16 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1 · Remaining Indefinite · Duration More than one year · Commission $2,283,500 · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 6 | 966.5 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 6 | 966.5 |
| By Discretionary | ||
| Discretionary | 6 | 966.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 6 | 966.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 263.0 | |
| United States Persons | 703.5 | |
| Total | 6 | 966.5 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Aaron Kantoff | Executive Officer | 14 | 2 | |
| Tadd Wessel | Executive Officer | 11 | 2 | |
| Samuel Hall | Executive Officer | 2 | 2 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| SC 13G | [0001913004] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Petrichor Healthcare Capital Management LP | Lumiradx Ltd | [2022-02-24] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
Balmoral Management II LP
✚
|
CA | 974.4 M |
|
Chicago Atlantic Advisers LLC
✚
|
IL | 970.3 M |
|
Factorial Funds Management LLC
✚
|
CA | 967.0 M |
|
Revival Healthcare Capital LLC
✚
|
TX | 964.3 M |
|
Bison Capital Asset Management LLC
✚
|
CA | 962.5 M |
|
Partners for Growth Managers LLC
✚
|
CA | 962.2 M |
|
White Deer Management LLC
✚
|
TX | 960.8 M |
|
Folium Capital LP
✚
|
MA | 960.3 M |
|
Clearlist Capital LLC
✚
|
NY | 959.8 M |
|
SPC Management Co Inc
✚
|
NJ | 959.6 M |